255 related articles for article (PubMed ID: 31601400)
1. Calpain in the cleavage of alpha-synuclein and the pathogenesis of Parkinson's disease.
Shams R; Banik NL; Haque A
Prog Mol Biol Transl Sci; 2019; 167():107-124. PubMed ID: 31601400
[TBL] [Abstract][Full Text] [Related]
2. Calpain activation and progression of inflammatory cycles in Parkinson's disease.
Gao A; McCoy HM; Zaman V; Shields DC; Banik NL; Haque A
Front Biosci (Landmark Ed); 2022 Jan; 27(1):20. PubMed ID: 35090325
[TBL] [Abstract][Full Text] [Related]
3. Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease.
Li Y; Xia Y; Yin S; Wan F; Hu J; Kou L; Sun Y; Wu J; Zhou Q; Huang J; Xiong N; Wang T
Front Immunol; 2021; 12():719807. PubMed ID: 34691027
[TBL] [Abstract][Full Text] [Related]
4. [Role of microglial activation induced by α-synuclein in pathogenesis of Parkinson's disease].
Qiao S; Luo JH; Jin JH
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 41(2):210-4. PubMed ID: 22499522
[TBL] [Abstract][Full Text] [Related]
5. O-GlcNAc modification inhibits the calpain-mediated cleavage of α-synuclein.
Levine PM; De Leon CA; Galesic A; Balana A; Marotta NP; Lewis YE; Pratt MR
Bioorg Med Chem; 2017 Sep; 25(18):4977-4982. PubMed ID: 28487126
[TBL] [Abstract][Full Text] [Related]
6. Reactive microglia enhance the transmission of exosomal α-synuclein via toll-like receptor 2.
Xia Y; Zhang G; Kou L; Yin S; Han C; Hu J; Wan F; Sun Y; Wu J; Li Y; Huang J; Xiong N; Zhang Z; Wang T
Brain; 2021 Aug; 144(7):2024-2037. PubMed ID: 33792662
[TBL] [Abstract][Full Text] [Related]
7. Alpha-Synuclein Proteins Promote Pro-Inflammatory Cascades in Microglia: Stronger Effects of the A53T Mutant.
Hoenen C; Gustin A; Birck C; Kirchmeyer M; Beaume N; Felten P; Grandbarbe L; Heuschling P; Heurtaux T
PLoS One; 2016; 11(9):e0162717. PubMed ID: 27622765
[TBL] [Abstract][Full Text] [Related]
8. Extracellular α-synuclein--a possible initiator of inflammation in Parkinson's disease.
Ren WQ; Tian ZM; Yin F; Sun JZ; Zhang JN
Pharmazie; 2016 Feb; 71(2):51-5. PubMed ID: 27004367
[TBL] [Abstract][Full Text] [Related]
9. Targeting alpha-synuclein for the treatment of Parkinson's disease.
Rohn TT
CNS Neurol Disord Drug Targets; 2012 Mar; 11(2):174-9. PubMed ID: 22483285
[TBL] [Abstract][Full Text] [Related]
10. Microglial exosomes facilitate α-synuclein transmission in Parkinson's disease.
Guo M; Wang J; Zhao Y; Feng Y; Han S; Dong Q; Cui M; Tieu K
Brain; 2020 May; 143(5):1476-1497. PubMed ID: 32355963
[TBL] [Abstract][Full Text] [Related]
11. Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation.
Dufty BM; Warner LR; Hou ST; Jiang SX; Gomez-Isla T; Leenhouts KM; Oxford JT; Feany MB; Masliah E; Rohn TT
Am J Pathol; 2007 May; 170(5):1725-38. PubMed ID: 17456777
[TBL] [Abstract][Full Text] [Related]
12. Exosomes of BV-2 cells induced by alpha-synuclein: important mediator of neurodegeneration in PD.
Chang C; Lang H; Geng N; Wang J; Li N; Wang X
Neurosci Lett; 2013 Aug; 548():190-5. PubMed ID: 23792198
[TBL] [Abstract][Full Text] [Related]
13. The relation between α-synuclein and microglia in Parkinson's disease: Recent developments.
Sanchez-Guajardo V; Tentillier N; Romero-Ramos M
Neuroscience; 2015 Aug; 302():47-58. PubMed ID: 25684748
[TBL] [Abstract][Full Text] [Related]
14. Activated microglia facilitate the transmission of α-synuclein in Parkinson's disease.
Zheng T; Zhang Z
Neurochem Int; 2021 Sep; 148():105094. PubMed ID: 34097990
[TBL] [Abstract][Full Text] [Related]
15. Pathological α-synuclein exacerbates the progression of Parkinson's disease through microglial activation.
Zhang QS; Heng Y; Yuan YH; Chen NH
Toxicol Lett; 2017 Jan; 265():30-37. PubMed ID: 27865851
[TBL] [Abstract][Full Text] [Related]
16. Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients.
Doorn KJ; Moors T; Drukarch B; van de Berg WDj; Lucassen PJ; van Dam AM
Acta Neuropathol Commun; 2014 Aug; 2():90. PubMed ID: 25099483
[TBL] [Abstract][Full Text] [Related]
17. Neuroinflammation and protein pathology in Parkinson's disease dementia.
Kouli A; Camacho M; Allinson K; Williams-Gray CH
Acta Neuropathol Commun; 2020 Dec; 8(1):211. PubMed ID: 33272323
[TBL] [Abstract][Full Text] [Related]
18. GM1 ganglioside modifies microglial and neuroinflammatory responses to α-synuclein in the rat AAV-A53T α-synuclein model of Parkinson's disease.
Schneider JS; Singh G; Williams CK; Singh V
Mol Cell Neurosci; 2022 May; 120():103729. PubMed ID: 35447351
[TBL] [Abstract][Full Text] [Related]
19. Temporal evolution of microglia and α-synuclein accumulation following foetal grafting in Parkinson's disease.
Olanow CW; Savolainen M; Chu Y; Halliday GM; Kordower JH
Brain; 2019 Jun; 142(6):1690-1700. PubMed ID: 31056668
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
